Sort by
Medicine and Dentistry
Intracranial Tumor
88%
Mycobacterium Tuberculosis
87%
Low and Middle Income Countries
80%
Diseases
64%
Tertiary Care
64%
Systematic Review
55%
Multidrug Resistant Tuberculosis
46%
Neoplasm
45%
Tumor
43%
Drug Resistance
43%
Antibiotic Resistance
42%
Ganglioglioma
40%
Pediatrics
38%
Prevalence
36%
Infection
35%
Neurosurgical Care
33%
Quinolone Derivative
31%
Lung Tuberculosis
31%
Biological Marker
28%
Androgen Receptor
27%
Isoniazid
24%
Breast Cancer
23%
Glioblastoma
22%
Neuro-Oncology
22%
Public Health
20%
Tuberculosis Treatment
20%
Meta-Analysis
20%
Helicobacter Pylori
20%
Multiple Myeloma
20%
Awareness
19%
Blood Culture
19%
Pathogen
18%
Diagnostic Accuracy
18%
In Vitro
17%
Diarrhea
17%
Sensitivity and Specificity
17%
Tuberculostatic Agent
17%
Cross Sectional Study
17%
Retrospective Study
16%
Antibiogram
16%
Odds Ratio
16%
Carbapenem
16%
Rifampicin
16%
Sputum
16%
Drug Sensitivity
15%
Atypical Mycobacterium
15%
Acinetobacter
15%
Irritable Bowel Syndrome
15%
Artificial Intelligence
14%
Adjuvant Therapy
14%
Ependymoma
14%
Overall Survival
13%
Mycobacterium Avium-Intracellulare Infection
13%
Penicillinase
13%
Intensive Care Unit
13%
Bloodstream Infection
13%
Case-Control Study
13%
Multidrug Resistance
13%
Patient Referral
13%
Health Care Cost
12%
Typhoid Fever
12%
Magnetic Resonance Imaging
12%
Pseudomonas aeruginosa
11%
Cancer Stem Cell
11%
Pediatrics Patient
11%
Cost-Effectiveness Analysis
11%
Progression Free Survival
11%
Salmonella Enterica Serovar Typhi
10%
Tuberculosis Diagnosis
10%
Agar
10%
Health Care Personnel
10%
Awake Craniotomy
10%
Treatment Outcome
10%
Extended Spectrum Beta Lactamase
10%
Rapid Diagnostic Test
10%
Weakness
10%
Growth Inhibition
9%
Drug Resistant Tuberculosis
9%
Imipenem
9%
Extrapulmonary Tuberculosis
9%
Receptor Expression
9%
Craniotomy
9%
Protein Kinase B
9%
Cell Marker
8%
Tumor Cell
8%
Prognostication
8%
Antiinfective Agent
8%
Infection Control
8%
Health System
8%
Medicine
8%
Messenger RNA
8%
Radiological Finding
8%
Fibroblast
8%
Pediatric Brain Tumor
8%
Carcinogenesis
7%
NMR Spectroscopy
7%
Intracranial Pressure
7%
Trephine
7%
Central Nervous System Tumor
7%
Ofloxacin
7%
Pharmacology, Toxicology and Pharmaceutical Science
Mycobacterium Tuberculosis
100%
Drug Resistance
72%
Diseases
56%
Antibiotic Resistance
49%
Infection
47%
Prevalence
47%
Isoniazid
44%
Quinolone Derivative
44%
Multi-Drug-Resistant Tuberculosis
35%
Tuberculostatic Agent
35%
Lung Tuberculosis
33%
Rifampicin
29%
Effusion
27%
Helicobacter Pylori
27%
Acinetobacter
25%
Multidrug Resistance
24%
Pseudomonas aeruginosa
21%
Penicillinase
21%
Cross-Sectional Study
20%
Salmonella Enterica Serovar Typhi
20%
Prostate Cancer
20%
Neoplasm
20%
Infectious Agent
19%
Agar
18%
Dengue
17%
Ethambutol
17%
Ofloxacin
17%
Antiinfective Agent
15%
Atypical Mycobacterium
15%
Dengue Hemorrhagic Fever
15%
Virus Infection
15%
Diarrhea
15%
Disease Severity
15%
Streptomycin
14%
Atypical Mycobacteriosis
13%
Dengue Virus
13%
Ventilator Associated Pneumonia
13%
Cholera
13%
Phosphatase
13%
Carcinogenesis
13%
Tensin
13%
Multiple Myeloma
13%
Glioblastoma
13%
Typhoid Fever
12%
Clarithromycin
12%
Androgen
12%
Shigella
11%
Staphylococcus Aureus
11%
Antibiotics
10%
Enzyme-Linked Immunosorbent Assay
10%
Imipenem
10%
Escherichia coli
10%
Vibrio Cholerae O1
10%
Mucin 1
10%
Nanoparticle
10%
Amoxicillin
9%
Aminoglycoside
9%
Leukemia
9%
Clavulanic Acid
9%
Pyrazinamide
9%
Irritable Colon
9%
Extensively Drug-Resistant Tuberculosis
8%
Ethionamide
8%
Blood-Brain Barrier
8%
Helicobacter Infection
8%
Biological Marker
8%
Capreomycin
8%
Candida
7%
Hormone Cancer Therapy
7%
Endocrine Therapy
7%
Combination Therapy
7%
Vibrio Cholerae
7%
Cotrimoxazole
7%
Carbapenem
6%
Bedaquiline
6%
Linezolid
6%
Levofloxacin
6%
HIV
6%
Enterobacteriaceae
6%
Ceftriaxone
6%
Pharmaceutical Market
6%
Case-Control Study
6%
Antimicrobial Agent
6%
Extended Spectrum Beta Lactamase
6%
Respiratory Tract Infection
6%
Macrolide
6%
Traumatic Brain Injury
6%
Cerebral Phaeohyphomycosis
6%
Mycobacterium Tuberculosis Complex
6%
4 Nitrobenzoic Acid
6%
Promyelocytic Leukemia
6%
Lipopolysaccharide
6%
Pleura Effusion
6%
Crizotinib
6%
Drug Delivery Vehicle
6%
Entamoeba Histolytica
6%
Hemolysin
6%
Androgen Receptor
6%
Side Effect
6%
Bloodstream Infection
6%
Biochemistry, Genetics and Molecular Biology
Mycobacterium Tuberculosis
47%
Pseudomonas aeruginosa
25%
Drug Resistance
25%
Acinetobacter
22%
Androgen Receptor
20%
Genomics
18%
Cross Sectional Study
17%
Programmed Cell Death
16%
Genotyping
15%
Stem Cell
14%
Single Nucleotide Polymorphism
14%
Salmonella Enterica Serovar Typhi
13%
MUC1
13%
Codon
13%
Helicobacter Pylori
13%
Cell Communication
13%
Enhancer Region
13%
Blastocystis Hominis
13%
Tensin
13%
Phosphatase
13%
Prevalence
12%
Antibiotic Resistance
12%
Gene Expression
12%
Polymerase Chain Reaction
11%
Scanning Electron Microscopy
11%
Aminoglycoside
11%
Staphylococcus Aureus
11%
Protein Kinase B
10%
Cancer Cell
10%
Imipenem
10%
Tyrosine Kinase Inhibitor
9%
Single-Nucleotide Polymorphism
9%
Carcinogenesis
9%
Cancer Stem Cell
9%
High Risk Population
9%
Anticancer
9%
MicroRNA
8%
Chromatin Structure
8%
Protein Kinase B
8%
Ki-67
8%
Capreomycin
8%
CD117
8%
Ponatinib
7%
CD44
7%
Zebra Fish
7%
Western Blot
7%
Real-Time Polymerase Chain Reaction
7%
Stem Cell Marker
7%
Indel
7%
Infectious Agent
7%
Immunoglobulin M
6%
Enterococcus faecium
6%
Molecular Typing
6%
Salmonella Enterica Serovar Paratyphi A
6%
DNA Methylation
6%
Dientamoeba
6%
DNA Profiling
6%
Bevacizumab
6%
Bloodstream Infection
6%
Glucuronosyltransferase
6%
Receptor Tyrosine Kinase
6%
Dasatinib
6%
Protein Content
6%
CD63
6%
CD9
6%
K562 Cells
6%
Nucleosome
6%
Transcription Factors
6%
Species Identification
6%
ULK2
6%
UVRAG
6%
Phosphoinositide 3-Kinase
6%
Cisplatin
6%
Growth Inhibition
6%
Transfusion Medicine
6%
Organogenesis
6%
Magnetic Resonance Imaging
6%
Cyclin D1
6%
Human Cytomegalovirus
6%
Retrospective Study
6%
Antigen Expression
6%
IC50
6%
Hyaluronan Synthase
6%
Hyaluronidase
6%
CD24
6%
Pseudogene
6%
Embryonic Stem Cell
6%
Lymphocyte
6%
Interferon
6%
XBP1
6%
Doxazosin
6%
Morphogenesis
6%
Gramicidin
6%
Expression Analysis
6%
Prophase
6%
Reassortment
6%
Eosin
6%
CD151
6%
TSG101
6%
Controlled Drug Release
6%